List view / Grid view
Positive first-in-human trial results have highlighted potential of a nanoparticle…
Positive first-in-human trial results have highlighted potential of a nanoparticle vaccine towards broadly neutralising against HIV.
Moderna and IAVI take steps towards HIV vaccination, with initiation…
Moderna and IAVI take steps towards HIV vaccination, with initiation of a trial dosing patients with HIV immunogens delivered by mRNA.
The vaccine was able to target the desired immune cells…
The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other viral diseases.
